Page last updated: 2024-08-16

ranitidine and Cancer of Gastrointestinal Tract

ranitidine has been researched along with Cancer of Gastrointestinal Tract in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19901 (16.67)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (16.67)24.3611
2020's4 (66.67)2.80

Authors

AuthorsStudies
Adami, HO; Chang, ET; Heide-Jørgensen, U; Nørgaard, M; Sørensen, HT; Trolle Andersen, I1
Adami, HO; Andersen, IT; Heide-Jørgensen, U; Nørgaard, M; Sørensen, HT1
Karp, I1
Fass, R; Ganocy, SJ; Kim, YD; Poels, KE; Shibli, F; Wang, J1
Hsu, K; Lankarani-Fard, A; Murphy, MC; Prommer, E1
Colin-Jones, DG; Langman, MJ; Lawson, DH; Vessey, MP1

Reviews

1 review(s) available for ranitidine and Cancer of Gastrointestinal Tract

ArticleYear
Pharmacologic Management of Malignant Bowel Obstruction: When Surgery Is Not an Option.
    Journal of hospital medicine, 2019, 06-01, Volume: 14, Issue:6

    Topics: Anti-Inflammatory Agents; Anti-Ulcer Agents; Dexamethasone; Gastrointestinal Neoplasms; Histamine H2 Antagonists; Hospitalists; Humans; Intestinal Obstruction; Palliative Care; Patient Care Team; Ranitidine

2019

Other Studies

5 other study(ies) available for ranitidine and Cancer of Gastrointestinal Tract

ArticleYear
Ranitidine Use and Risk of Upper Gastrointestinal Cancers.
    Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2021, Volume: 30, Issue:12

    Topics: Adult; Case-Control Studies; Denmark; Dimethylnitrosamine; Female; Gastrointestinal Neoplasms; Histamine H2 Antagonists; Humans; Male; Middle Aged; Proportional Hazards Models; Prospective Studies; Ranitidine; Registries

2021
Ranitidine Use and Risk of Upper Gastrointestinal Cancers-Reply.
    Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2022, 04-01, Volume: 31, Issue:4

    Topics: Gastrointestinal Neoplasms; Humans; Ranitidine; Upper Gastrointestinal Tract

2022
"Ranitidine Use and Risk of Upper Gastrointestinal Cancers"-Letter.
    Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2022, 04-01, Volume: 31, Issue:4

    Topics: Gastrointestinal Neoplasms; Humans; Ranitidine; Upper Gastrointestinal Tract

2022
No association between chronic use of ranitidine, compared with omeprazole or famotidine, and gastrointestinal malignancies.
    Alimentary pharmacology & therapeutics, 2021, Volume: 54, Issue:5

    Topics: Animals; Famotidine; Gastroesophageal Reflux; Gastrointestinal Neoplasms; Humans; Omeprazole; Ranitidine; United States

2021
Postmarketing surveillance of the safety of cimetidine: mortality during second, third, and fourth years of follow up.
    British medical journal (Clinical research ed.), 1985, Oct-19, Volume: 291, Issue:6502

    Topics: Aged; Cimetidine; Duodenal Ulcer; Evaluation Studies as Topic; Female; Gastrointestinal Diseases; Gastrointestinal Neoplasms; Humans; Male; Middle Aged; Peptic Ulcer; Peptic Ulcer Hemorrhage; Product Surveillance, Postmarketing; Ranitidine; Respiratory Tract Neoplasms; Risk; United Kingdom; Urologic Diseases

1985